Characteristics of polymedicated (≥ 4) elderly: A survey in a community-dwelling population aged 60 years and over

Journal of Nutrition, Health and Aging

Volumn 18, Issue 1, 2014, Pages 87-91

  Husson, N ^a   Watfa, G ^a,b,c   Laurain, M C ^a   Perret Guillaume, C ^a,c   Niemier, J Y ^a,c   Miget, P ^d   Benetos, Athanase ^a,b,c  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d Preventive Medical Centre (CMP) Nancy   (France)

Author keywords

drug use; elderly; Polypharmacy

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; COMMUNITY ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; EDUCATIONAL STATUS; FALLING; FEMALE; GERIATRIC ASSESSMENT; HEALTH STATUS; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; MIDDLE AGED; NORMAL HUMAN; PHYSICAL ACTIVITY; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF CONCEPT; SENIOR CENTER; SOCIAL PSYCHOLOGY;

ACCIDENTAL FALLS; AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; EXERCISE; FEMALE; GERIATRIC ASSESSMENT; HEALTH CARE SURVEYS; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERCEPTION; POLYPHARMACY; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEDENTARY LIFESTYLE;

EID: 84893826912     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-013-0337-8     Document Type: Article

References (26)

1. o 1332 1-4.
2. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20(11):817-832. (Pubitemid 37159599)
3. Montamat SC, Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med. 1992 Feb;8(1):143-158.
4. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007 Dec;5(4):345-351.
5. Kroenke K. Polypharmacy. Causes, consequences, and cure. Am J Med. 1985 Aug;79(2):149-152. (Pubitemid 15246241)
6. Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2006 Feb;61(2):218-223. (Pubitemid 43382615)
7. Derouesne C, Poitreneau J, Hugonot L, Kalafat M, Dubois B, Laurent B. [Mini-Mental State Examination:a useful method for the evaluation of the cognitive status of patients by the clinician. Consensual French version]. Presse Med. 1999 Jun 12;28(21):1141-1148.
8. Vellas BJ, Wayne SJ, Romero L, Baumgartner RN, Rubenstein LZ, Garry PJ. Oneleg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc. 1997 Jun;45(6):735-738. (Pubitemid 27248784)
9. Bischoff HA, Stahelin HB, Monsch AU, Iversen MD, Weyh A, von Dechend M, et al. Identifying a cut-off point for normal mobility: a comparison of the timed 'up and go' test in community-dwelling and institutionalised elderly women. Age Ageing. 2003 May;32(3):315-320. (Pubitemid 36622237)
10. Whitney SL, Wrisley DM, Marchetti GF, Gee MA, Redfern MS, Furman JM. Clinical measurement of sit-to-stand performance in people with balance disorders: validity of data for the Five-Times-Sit-to-Stand Test. Phys Ther. 2005 Oct;85(10):1034-1045. (Pubitemid 41396003)
11. Benetos A, Thomas F, Pannier B, Bean K, Jego B, Guize L. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am J Cardiol. 2008 Jul 15;102(2):188-191.
12. Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The development of polypharmacy. A longitudinal study. Fam Pract. 2000 Jun;17(3):261-267. (Pubitemid 30386721)
13. Hanlon JT, Landerman LR, Wall WE, Jr., Horner RD, Fillenbaum GG, Dawson DV, et al. Is medication use by community-dwelling elderly people influenced by cognitive function? Age Ageing. 1996 May;25(3):190-196. (Pubitemid 26152033)
14. Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging. 2009;26(6):493-503.
15. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002 Aug;55(8):809-817.
16. Simons LA, Tett S, Simons J, Lauchlan R, McCallum J, Friedlander Y, et al. Multiple medication use in the elderly. Use of prescription and non-prescription drugs in an Australian community setting. Med J Aust. 1992 Aug 17;157(4):242-246.
17. Iliffe S, Haines A, Gallivan S, Booroff A, Goldenberg E, Morgan P. Assessment of elderly people in general practice. 2. Functional abilities and medical problems. Br J Gen Pract. 1991 Jan;41(342):13-15.
18. Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol. 2000 Sep;56(6-7):501-509.
19. Gause-Nilsson I, Gherman S, Kumar Dey D, Kennerfalk A, Steen B. Prevalence of metabolic syndrome in an elderly Swedish population. Acta Diabetol. 2006 Dec;43(4):120-126. (Pubitemid 46072207)
20. Genton L, Karsegard VL, Chevalley T, Kossovsky MP, Darmon P, Pichard C. Body composition changes over 9 years in healthy elderly subjects and impact of physical activity. Clin Nutr. Feb 14.
21. Akbulut G, Koksal E, Bilici S, Acar Tek N, Yildiran H, Karadag MG, et al. Metabolic syndrome (MS) in elderly: A cross sectional survey. Arch Gerontol Geriatr. Dec 14.
22. Haider SI, Johnell K, Thorslund M, Fastbom J. Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden. Clin Ther. 2008 Feb;30(2):419-427. (Pubitemid 351474380)
23. Lahelma E, Kivela K, Roos E, Tuominen T, Dahl E, Diderichsen F, et al. Analysing changes of health inequalities in the Nordic welfare states. Soc Sci Med. 2002 Aug;55(4):609-625. (Pubitemid 34727358)
24. Nielsen MW, Hansen EH, Rasmussen NK. Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol. 2003 Nov;59(8-9):677-684. (Pubitemid 37494538)
25. Kelly DM, Frick EM, Hale LS. How the medication review can help to reduce risk of falls in older patients. JAAPA. Apr;24(4):30-34, 55.
26. Kojima T, Akishita M, Nakamura T, Nomura K, Ogawa S, Iijima K, et al. Association of polypharmacy with fall risk among geriatric outpatients. Geriatr Gerontol Int. May 5.